Shilpa CDMO invests $50 million to expand peptide manufacturing capacity EP News Bureau Nov 4, 2026 The expansion will add 10 KL of SPPS reactor capacity and establish six parallel cGMP manufacturing lines to support peptide…
Neuland Laboratories partners with LIR Life Sciences for transdermal GLP-1 peptide development EP News Bureau May 7, 2026 Collaboration focuses on CPP platform development for obesity treatment programme
